Latest & greatest articles for gestational diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for gestational diabetes

61. Flowchart: Gestational diabetes mellitus postpartum care

Flowchart: Gestational diabetes mellitus postpartum care Document Number: F15.33-3-V1-R20 Department of Health Queensland Clinical Guidelines State of Queensland (Queensland Health) 2015 http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Queensland Clinical Guidelines, Guidelines@health.qld.gov.au Postpartum care for all GDM Cease Metformin and/or Insulin immediately after birth (vaginal or CS) BGL monitoring • Target BGL = 7.0 mmol/L • Monitor BGL QID for 24 hours (preprandial (...) and before bed) • If all preprandial BGL between 4-7 mmol/L, cease monitoring 24 hours after birth BGL 7.0 mmol/L • If any preprandial BGL > 7.0 mmol/L o Seek medical review o Continue BGL monitoring • Insulin rarely required postpartum o If indicated, prescribe lower dose than required during pregnancy IV therapy (if any) • If BGL = 4.0 mmol/L and diet tolerated cease mainline IV fluids after birth All GDM Pharmacological therapy? Insulin or Metformin Queensland Clinical Guideline: Gestational diabetes

2015 Queensland Health

62. Flowchart: Intrapartum management for gestational diabetes mellitus requiring Insulin and/or Metformin

Flowchart: Intrapartum management for gestational diabetes mellitus requiring Insulin and/or Metformin Document Number: F15.33--2-V1-R20 Department of Health Queensland Clinical Guidelines State of Queensland (Queensland Health) 2015 http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Queensland Clinical Guidelines, Guidelines@health.qld.gov.au Intrapartum management for GDM requiring Insulin and/or Metformin Metformin • Cease when labour established Insulin • Cease when labour

2015 Queensland Health

63. Flowchart: Gestational diabetes mellitus, screening and Diagnosis

Flowchart: Gestational diabetes mellitus, screening and Diagnosis Document Number: F15.33-1-V1-R20 Department of Health Queensland Clinical Guidelines State of Queensland (Queensland Health) 2015 http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Queensland Clinical Guidelines, Guidelines@health.qld.gov.au Screening and diagnosis of GDM 24-28 weeks gest 2 hour 75 g OGTT Routine antenatal care Risk factors? OGTT normal? BGL: Blood glucose level BMI: Body Mass Index DM: Diabetes Mellitus (...) GDM: Gestational Diabetes Mellitus gest: gestational age HbA1c: Glycated haemoglobin OGTT: Oral glucose tolerance test =: greater than or equal to : greater than Queensland Clinical Guideline: Gestational diabetes mellitus. Guideline No: MN15.33-V1-R20 Assess all women for risk factors GDM care GDM diagnosis OGTT (preferred test for diagnosis) One or more of: • Fasting = 5.1 mmol/L • 1 hour = 10 mmol/L • 2 hour = 8.5 mmol/L HbA1c (if OGTT not suitable) • 1st trimester only • Result = 41 mmol/mol

2015 Queensland Health

64. Gestational diabetes mellitus

BMI: Body Mass Index DM: Diabetes Mellitus GDM: Gestational Diabetes Mellitus gest: gestational age HbA1c: Glycated haemoglobin OGTT: Oral glucose tolerance test =: greater than or equal to : greater than Queensland Clinical Guideline: Gestational diabetes mellitus. Guideline No: MN15.33-V1-R20 Assess all women for risk factors GDM care GDM diagnosis OGTT (preferred test for diagnosis) One or more of: • Fasting = 5.1 mmol/L • 1 hour = 10 mmol/L • 2 hour = 8.5 mmol/L HbA1c (if OGTT not suitable (...) • Maternal age = 40 years • Family history DM (1 st degree relative or sister with GDM) • Previous macrosomia (birth weight > 4500 g or > 90 th percentile • Previous perinatal loss • Polycystic Ovarian Syndrome • Medications (corticosteroids, antipsychotics) • Multiple pregnancy Queensland Clinical Guideline: Gestational diabetes mellitus Refer to online version, destroy printed copies after use Page 4 of 38 Flowchart: Intrapartum management for GDM requiring Insulin and/or Metformin Metformin • Cease

2015 Queensland Health

65. Growing evidence that maternal gestational diabetes increases risk of autism in offspring

Growing evidence that maternal gestational diabetes increases risk of autism in offspring Growing evidence that maternal gestational diabetes increases risk of autism in offspring | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Growing evidence that maternal gestational diabetes increases risk of autism in offspring Article Text Causes and risk factors Growing evidence that maternal gestational diabetes increases risk of autism in offspring

2015 Evidence-Based Mental Health

66. Adherence to healthy lifestyle and risk of gestational diabetes mellitus: prospective cohort study. Full Text available with Trip Pro

Adherence to healthy lifestyle and risk of gestational diabetes mellitus: prospective cohort study. To quantify the association between a combination of healthy lifestyle factors before pregnancy (healthy body weight, healthy diet, regular exercise, and not smoking) and the risk of gestational diabetes.Prospective cohort study.Nurses' Health Study II, United States.20,136 singleton live births in 14,437 women without chronic disease.Self reported incident gestational diabetes diagnosed (...) by a physician, validated by medical records in a previous study.Incident first time gestational diabetes was reported in 823 pregnancies. Each lifestyle factor measured was independently and significantly associated with risk of gestational diabetes. The combination of three low risk factors (non-smoker, ≥ 150 minutes a week of moderate to vigorous physical activity, and healthy eating (top two fifths of Alternate Healthy Eating Index-2010 adherence score)) was associated with a 41% lower risk

2014 BMJ

67. Effect of excess gestational weight gain on pregnancy outcomes in women with type 1 diabetes (Abstract)

Effect of excess gestational weight gain on pregnancy outcomes in women with type 1 diabetes To evaluate the prevalence and clinical effects of excess gestational weight gain on birth weight and other pregnancy outcomes in women with type 1 diabetes.We performed a retrospective cohort study of women with type 1 diabetes delivered between 2009 and 2012. Patients with excess weight gain were identified using the 2009 Institute of Medicine weight gain recommendations adjusted for gestational age (...) in both normal-weight and overweight or obese women with type 1 diabetes. Interventions designed to limit excess gestational weight gain may reduce the risk for fetal overgrowth in women with type 1 diabetes.II.

2014 EvidenceUpdates

68. The effects of mindfulness eating and yoga exercise on blood sugar levels of pregnant women with gestational diabetes mellitus (Abstract)

The effects of mindfulness eating and yoga exercise on blood sugar levels of pregnant women with gestational diabetes mellitus This randomized controlled trial was carried out to investigate the effect of mindfulness eating and yoga exercise on blood sugar levels among pregnant Thai women with GDM.Interventions promoting achievement of good glycemic control result in desired pregnancy outcomes. Little is known about the health benefits of mindfulness eating and yoga exercise on blood sugar

2014 EvidenceUpdates Controlled trial quality: uncertain

69. Reminder systems for women with previous gestational diabetes mellitus to increase uptake of testing for type 2 diabetes or impaired glucose tolerance. (Abstract)

Reminder systems for women with previous gestational diabetes mellitus to increase uptake of testing for type 2 diabetes or impaired glucose tolerance. The early postpartum period is an important time in which to identify the risk of diabetes in women with a history of gestational diabetes mellitus (GDM). Oral glucose tolerance and other tests can help guide lifestyle management and monitoring to reduce the future risk of type 2 diabetes mellitus.To assess whether reminder systems increase (...) the uptake of testing for type 2 diabetes or impaired glucose tolerance in women with a history of GDM.We searched MEDLINE and EMBASE (last searched 1 June 2013) and The Cochrane Library (last searched April 2013).We included randomised trials of women who had experienced GDM in the index pregnancy and who were then sent any modality of reminder (or control) to complete a test for type 2 diabetes after giving birth.Two authors independently screened titles and abstracts for relevance. One author

2014 Cochrane

70. Probiotics for preventing gestational diabetes. Full Text available with Trip Pro

Probiotics for preventing gestational diabetes. Gestational diabetes mellitus (GDM) is associated with a range of adverse pregnancy outcomes for mother and infant. The prevention of GDM using lifestyle interventions has proven difficult. The gut microbiome (the composite of bacteria present in the intestines) influences host inflammatory pathways, glucose and lipid metabolism and, in other settings, alteration of the gut microbiome has been shown to impact on these host responses. Probiotics (...) to five possible trials) were found. We included one study (six trial reports) involving 256 women. Four other studies are ongoing.The included trial consisted of three treatment arms: probiotic with dietary intervention, placebo and dietary intervention, and dietary intervention alone; it was at a low risk of bias. The study reported primary outcomes of a reduction in the rate of gestational diabetes mellitus (risk ratio (RR) 0.38, 95% confidence interval (CI) 0.20 to 0.70), with no statistical

2014 Cochrane

71. ADIPS Consensus guidelines for the testing and diagnosis of gestational diabetes mellitus in Australia

ADIPS Consensus guidelines for the testing and diagnosis of gestational diabetes mellitus in Australia Page 1 of 8 ADIPS Consensus Guidelines for the Testing and Diagnosis of Gestational Diabetes Mellitus in Australia Nankervis A, McIntyre HD, Moses R, Ross GP, Callaway L, Porter C, Jeffries W, Boorman C, De Vries B, McElduff A for the Australasian Diabetes in Pregnancy Society The Australasian Diabetes in Pregnancy Society (ADIPS) originally formulated recommendations for the testing (...) and diagnosis of gestational diabetes mellitus (GDM) in 1991. 1 These guidelines were primarily based on expert opinion. With some local variations, the ADIPS guidelines have been used nationally since that time. In the light of more recent evidence, ADIPS has elected to revise these guidelines in the current document. Recommendations for future research are summarized at the end of this document. The Hyperglycemia and Adverse Pregnancy Outcome study (HAPO) published in 2008 2 was a large, prospective

2014 Clinical Practice Guidelines Portal

72. The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel Full Text available with Trip Pro

The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel Marseille E, Lohse N, Jiwani A, Hod M, Seshiah V, Yajnik CS (...) , Arora GP, Balaji V, Henriksen O, Lieberman N, Chen R, Damm P, Metzger BE, Kahn JG Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to assess the cost-effectiveness of screening for gestational diabetes mellitus

2014 NHS Economic Evaluation Database.

73. Screening for Gestational Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement. Full Text available with Trip Pro

Screening for Gestational Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement. Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for gestational diabetes mellitus (GDM).The USPSTF reviewed the evidence on the accuracy of screening tests for GDM, the benefits and harms of screening before and after 24 weeks of gestation, and the benefits and harms of treatment in the mother and infant.This recommendation applies to pregnant (...) women who have not been previously diagnosed with type 1 or 2 diabetes mellitus.The USPSTF recommends screening for GDM in asymptomatic pregnant women after 24 weeks of gestation. (B recommendation)The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for GDM in asymptomatic pregnant women before 24 weeks of gestation. (I statement).

2014 Annals of Internal Medicine

74. Gestational Diabetes Mellitus Screening & Diagnosis 2011

Gestational Diabetes Mellitus Screening & Diagnosis 2011 April 2014 Please be informed that the PSBC guideline you are looking for; Obstetric Guideline Gestational Diabetes Mellitus Screening and Diagnosis is under revision but still available by request. An updated clinical practice guideline is available through the: Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada – see Chapter 36 for Diabetes and Pregnancy at http (...) ://guidelines.diabetes.ca/Browse/Chapter36 The PSBC guideline for Diabetes Mellitus and Pregnancy Type 1 & 2 is also being revised. West Tower, 350-555 West 12th Avenue Vancouver, BC V5Z 3X7 Main Line: 604.877.2121 Fax: 604.872.1987 www.perinatalservicesbc.ca

2014 British Columbia Perinatal Health Program

75. Screening and Diagnosis of Gestational Diabetes Mellitus*

Screening and Diagnosis of Gestational Diabetes Mellitus* Screening and Diagnosis of Gestational Diabetes Mellitus | National Guideline Clearinghouse success fail JUL Aug 12 2018 2019 30 Sep 2016 - 13 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed (...) In Username or Email * Password * Remember Me Don't have an account? The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018 because federal funding through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our . Guideline Synthesis Screening and Diagnosis of Gestational Diabetes Mellitus Guidelines Being Compared: The Endocrine Society (Endocr Soc) Diabetes and pregnancy: an Endocrine Society

2014 National Guideline Clearinghouse (partial archive)

76. Cohort study: Gestational diabetes is associated with increased risk of urinary incontinence up to 2?years postpartum

Cohort study: Gestational diabetes is associated with increased risk of urinary incontinence up to 2?years postpartum Gestational diabetes is associated with increased risk of urinary incontinence up to 2 years postpartum | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Gestational diabetes is associated with increased risk of urinary incontinence up to 2 years postpartum Article Text Midwifery Cohort study Gestational diabetes is associated

2014 Evidence-Based Nursing

77. Gestational Diabetes Mellitus, Screening

Gestational Diabetes Mellitus, Screening Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation to see the latest documents available. Recommendation Summary Population Recommendation Asymptomatic Pregnant Women, After 24 Weeks of Gestation The USPSTF recommends screening for gestational diabetes mellitus (GDM) in asymptomatic pregnant women after 24 weeks of gestation. B Asymptomatic Pregnant Women, Before 24 Weeks (...) of Gestation The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for GDM in asymptomatic pregnant women before 24 weeks of gestation. I View the Clinical Summary in Population Asymptomatic pregnant women after 24 weeks of gestation Asymptomatic pregnant women before 24 weeks of gestation Recommendation Screen for gestational diabetes mellitus (GDM). Grade: B No recommendation. Grade: I statement Risk Assessment Risk factors that increase

2014 U.S. Preventive Services Task Force

78. Cohort study: Gestational diabetes: higher animal protein intake during pregnancy is associated with increased risk, and higher vegetable protein intake with decreased risk

Cohort study: Gestational diabetes: higher animal protein intake during pregnancy is associated with increased risk, and higher vegetable protein intake with decreased risk Gestational diabetes: higher animal protein intake during pregnancy is associated with increased risk, and higher vegetable protein intake with decreased risk | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser (...) at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Gestational diabetes: higher animal protein intake during

2014 Evidence-Based Nursing

79. Systematic review with meta-analysis: Treating mild gestational diabetes yields benefits with little or no evidence of harms

diabetes yields benefits with little or no evidence of harms Donald Coustan Statistics from Altmetric.com Commentary on: Hartling L , Dryden DM , Guthrie A , et al . Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research . Context The screening, diagnosis and treatment of gestational diabetes have been a contentious topic for at least (...) Systematic review with meta-analysis: Treating mild gestational diabetes yields benefits with little or no evidence of harms Treating mild gestational diabetes yields benefits with little or no evidence of harms | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password

2014 Evidence-Based Medicine

80. Insufficient evidence for exercise preventing gestational diabetes mellitus

Insufficient evidence for exercise preventing gestational diabetes mellitus Insufficient evidence for exercise preventing gestational diabetes mellitus | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms Insufficient evidence for exercise preventing gestational diabetes mellitus Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2013 Cochrane PEARLS